Keloids Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Keloids are the growth of extra scar tissue where the skin has healed after an injury. Symptoms include flesh-colored, red, or pink, lumpy (nodular) or ridged, irritated from friction such as rubbing on clothing, and tender and itchy. Risk factors include age and family history. Treatment includes corticosteroids, radiation, surgical removal, and silicone gel or patches.

The Keloids pipeline drugs market research report provides comprehensive information on the therapeutics under development for Keloids, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report offers an overview of key players involved in therapeutic development for Keloids and features dormant and discontinued projects.

Keloids Pipeline Drugs Market Segmentation by Targets

Some of the targets of the Keloids pipeline drugs market are Amphiregulin, Bifunctional Glutamate/Proline tRNA Ligase, Gap Junction Alpha 1 Protein, Interleukin 4 Receptor Subunit Alpha, microRNA 29B, and Phosphodiesterase 4 among others.

Keloids Pipeline Drugs Market Analysis, by Targets

 For more Keloids pipeline drugs market target insights, download a free report sample

Keloids Pipeline Drugs Market Segmentation by Mechanisms of Action

Some of the key mechanisms of action of the Keloids pipeline drugs market are Amphiregulin Inhibitor, Bifunctional Glutamate/Proline tRNA Ligase Inhibitor, Gap Junction Alpha 1 Protein Inhibitor, Interleukin 4 Receptor Subunit Alpha Antagonist, microRNA 29B Activator, Phosphodiesterase 4 Inhibitor among others.

Keloids Pipeline Drugs Market Analysis, by Mechanisms of Action

 For more mechanisms of action insights into the Keloids pipeline drugs market, download a free report sample

Keloids Pipeline Drugs Market Segmentation by Routes of Administration

The key routes of administration in the Keloids pipeline drugs market are topical, intradermal, intravenous, subcutaneous, intratumor, and oral. Topical leads the Keloids pipeline drugs market in terms of RoA.

Keloids Pipeline Drugs Market Analysis, by Routes of Administration

For more routes of administration insights into the Keloids pipeline drugs market, download a free report sample

Keloids Pipeline Drugs Market Segmentation by Molecule Types

The molecule types in the Keloids pipeline drugs market are Small Molecule, Antisense RNAi Oligonucleotide, Antisense Oligonucleotide, Monoclonal Antibody, Polysaccharide, and Synthetic Peptide. Small Molecule leads the Keloids pipeline drugs market in terms of molecule types.

Keloids Pipeline Drugs Market Analysis, by Molecule Types

For more molecule-type insights into the Keloids pipeline drugs market, download a free report sample

Keloids Pipeline Drugs Market - Competitive Landscape

Some of the key companies in the Keloids pipeline drugs market are CellionBioMed Inc, Daewoong Pharmaceutical Co Ltd, Lemonex Inc, Next Science Ltd, Regeneron Pharmaceuticals Inc, siRNAgen Therapeutics Corp, Sirnaomics Ltd, and among others. CellionBioMed Inc has the highest number of products under development.

Keloids Pipeline Drugs Market Analysis, by Companies

To know more about the Keloids pipeline drugs companies, download a free report sample

Keloids Pipeline Drugs Market Report Overview

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Keloids.
• The pipeline guide reviews pipeline therapeutics for Keloids by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Keloids therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Keloids therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews the latest news related to pipeline therapeutics for Keloids

Reasons to Buy

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Keloids.
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding the Keloids pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.